Related Experiment Videos
Apoptotic action of estrogen
1Department of Internal Medicine, University of Virginia School of Medicine, Charlottesville, VA 22901, USA. rs5wf@virginia.edu
Apoptosis : an International Journal on Programmed Cell Death
|January 3, 2003
Summary
Estrogen, while known to promote cancer, can paradoxically induce breast cancer regression by triggering apoptosis, or programmed cell death. This estrogen-mediated tumor recession involves estrogen receptors and Fas/FasL pathways, offering potential therapeutic strategies.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Estrogen acts as a mitogen, promoting cell proliferation and inhibiting cell death.
- Estrogen is implicated in the development of breast and uterine cancers.
- High-dose estrogen can paradoxically induce regression of hormone-dependent breast cancer in postmenopausal women.
Purpose of the Study:
- To review the latest findings on estrogen's apoptotic effects in various cell models, including breast cancer cells.
- To summarize the potential mechanisms underlying estrogen-mediated apoptosis in cancer.
- To discuss implications for pharmacological control of breast cancer in postmenopausal women.
Main Methods:
- Review of current literature on estrogen's effects on cell apoptosis.
- Focus on estrogen-receptor-dependent mechanisms.
- Examination of the role of Fas/FasL pathways in estrogen-induced cell death.
Main Results:
- Estrogen-induced apoptosis is a significant factor in decreasing cell numbers.
- The Fas/FasL pathway activation is crucial in estrogen-mediated tumor recession.
- Estrogen's apoptotic effects are dependent on estrogen receptor signaling.
Conclusions:
- Estrogen can induce apoptosis in cancer cells, leading to tumor regression.
- Understanding estrogen's apoptotic mechanisms may lead to novel breast cancer therapies.
- Estrogen therapy warrants further investigation for managing hormone-dependent breast cancer in postmenopausal women.